Praluent and Juxtapid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Praluent (alirocumab) and Juxtapid (lomitapide mesylate). Common drug interactions include hepatic enzyme increased among females and cerebrovascular accident among males.
The phase IV clinical study analyzes what interactions people have when they take Praluent and Juxtapid. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.
What is Praluent?
Praluent has active ingredients of alirocumab. It is often used in high blood cholesterol. eHealthMe is studying from 24,963 Praluent users. Check the latest studies of Praluent.
What is Juxtapid?
Juxtapid has active ingredients of lomitapide mesylate. eHealthMe is studying from 4,279 Juxtapid users. Check the latest studies of Juxtapid.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
78 people who take Praluent and Juxtapid together, and have interactions are studied.

What are the common drug interactions of Praluent and Juxtapid, by gender? *:
female:
- Hepatic enzyme increased
- Diarrhoea
- Acute pulmonary oedema (sudden deposit of fluid in the lung))
- Acute respiratory failure
- Cardiac arrest
- Faeces discoloured
- Fatigue (feeling of tiredness)
- Haematochezia (passage of stools containing blood)
- Large intestinal haemorrhage (bleeding in large intestine)
- Alanine aminotransferase increased
male:
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Drug ineffective
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Diarrhoea
- Abdominal pain
- Abdominal discomfort
- Low density lipoprotein decreased (cholesterol decreased)
- Fatigue (feeling of tiredness)
What are the common drug interactions of Praluent and Juxtapid, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Drug ineffective
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Diarrhoea
- Bowel movement irregularity
- Flatulence (flatus expelled through the anus)
- Infrequent bowel movements
- Micturition urgency (urgency to pass the urine)
- Motion sickness (travel sickness)
- Nasopharyngitis (inflammation of the nasopharynx)
40-49:
- Liver disorder (liver diseases)
50-59:
- Hepatic enzyme increased
- Back pain
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Abdominal discomfort
- Diarrhoea
- Neck pain
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
60+:
- Diarrhoea
- Fatigue (feeling of tiredness)
- Peripheral vascular disorder
- Pneumonia
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Contusion (a type of hematoma of tissue in which capillaries)
- Dizziness
- Drug administration error
- Fall
What are the existing conditions these people have? *
- Low Density Lipoprotein: 28 people, 35.90%
- Low Density Lipoprotein Abnormal (cholesterol abnormal): 12 people, 15.38%
- Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 8.97%
- Depression: 6 people, 7.69%
- Stable Angina (a constant chest pain): 4 people, 5.13%
- Iron Deficiency Anaemia: 4 people, 5.13%
- High Blood Pressure: 4 people, 5.13%
* Approximation only. Some reports may have incomplete information.
Do you take Praluent and Juxtapid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Praluent and Juxtapid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Praluent:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Juxtapid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Praluent and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Juxtapid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on alirocumab and lomitapide mesylate (the active ingredients of Praluent and Juxtapid, respectively), and Praluent and Juxtapid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zyprexa cause Influenza Like Illness? - 7 seconds ago
- Could Zyprexa cause Temporal Arteritis? - 9 seconds ago
- Drug interactions of Drospirenone and Spironolactone - 10 seconds ago
- Drug interactions of Q10 and Dalfampridine - 12 seconds ago
- Glucosamine And Chondroitin Sulfate And Msm vs. Oxycodone, side effect and effectiveness comparison - 13 seconds ago
- Multiple Myeloma and Respiratory Syncytial Virus Infection - 13 seconds ago
- Could Prolia cause Blood Alkaline Phosphatase Increased? - 19 seconds ago
- Could Dexamethasone Sodium Phosphate cause Migraine With Aura? - 19 seconds ago
- Drug interactions of Stalevo 100 and Morphine - 20 seconds ago
- Drug interactions of Diphen and Unituxin - 20 seconds ago